Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Applied DNA Sciences is a diagnostics & research business based in the US. Applied DNA Sciences shares (APDN) are listed on the NASDAQ and all prices are listed in US Dollars. Applied DNA Sciences employs 61 staff and has a trailing 12-month revenue of around $18.2 million.
Finder Award
SoFi Invest
tastyworks
| Latest market close | $1.47 |
|---|---|
| 52-week range | $0.62 - $7.35 |
| 50-day moving average | $1.49 |
| 200-day moving average | $1.76 |
| Wall St. target price | $4.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.91 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.47 from 2023-01-26
| 1 week (2023-01-20) | -5.16% |
|---|---|
| 1 month (2022-12-27) | 14.84% |
| 3 months (2022-10-26) | -16.00% |
| 6 months (2022-07-28) | 110.27% |
| 1 year (2022-01-28) | -54.06% |
|---|---|
| 2 years (2021-01-28) | -85.08% |
| 3 years (2020-01-28) | 3.89 |
| 5 years (2018-01-26) | 1.58 |
| Revenue TTM | $18.2 million |
|---|---|
| Gross profit TTM | $5.1 million |
| Return on assets TTM | -47.6% |
| Return on equity TTM | -68.85% |
| Profit margin | -45.51% |
| Book value | $1.00 |
| Market capitalisation | $20 million |
TTM: trailing 12 months
We're not expecting Applied DNA Sciences to pay a dividend over the next 12 months.
Applied DNA Sciences's shares were split on a 1:40 basis on 31 October 2019. So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Applied DNA Sciences shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Applied DNA Sciences shares which in turn could have impacted Applied DNA Sciences's share price.
Over the last 12 months, Applied DNA Sciences's shares have ranged in value from as little as $0.62 up to $7.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied DNA Sciences's is 0.5483. This would suggest that Applied DNA Sciences's shares are less volatile than average (for this exchange).
Applied DNA Sciences, Inc. , a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR)-based MDx testing services for the Monkeypox virus; and MDx test kits and related supplies, as well as validates pharmacogenetics (PGx) testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, leather, pharmaceuticals, nutraceuticals, and other products; SigNify IF portable DNA readers and SigNify consumable reagent test kits, which offers a front-line solution for supply chain integrity backed with forensic-level molecular tag authentication; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
